Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Heart Attacks, Cancer and strokes. Preventative approaches -- Ignore unavailable to you. Want to Upgrade?

To: LindyBill who wrote (747)	8/11/2008 8:17:46 AM
From: jrhana	Respond to of 39296

Good to have all these scams exposed.

To: LindyBill who wrote (747)	9/26/2008 5:31:47 PM
From: jrhana	Read Replies (1) \| Respond to of 39296

This was excellent from Dr. Davis: <Chelation Chelation is the practice of administering a substance called EDTA, either intravenously or orally, to bind "toxins". EDTA is indeed a legitimate and proven treatment for lead poisoning. However, some advocates make extravagant claims over "curing" heart disease. This practice has proven profitable for its practitioners who often charge substantial amounts to administer the intravenous agent. Chelation agents are also available in health food stores as an oral "supplement". To date, five small studies have examined the value of chelation. All were relatively weak studies based on "soft" measures like exercise time on a treadmill. Nonetheless, all studies suggested no benefit from chelation. We've had several patients who, on their own, underwent thousands of dollars of chelation therapy and assessed their response by heart scan score. These people experienced marked progression of their plaque, i.e., increased heart scan scores— similar to that experienced with no treatment whatsoever. Because of the vigorous advocacy for chelation from its practitioners, the National Institutes of Health is conducting a large multi-center trial applying chelation in the manner practiced by its advocates to determine once and for all whether the practice has any merit. We are skeptical. In the meantime, the bulk of evidence suggests chelation is without benefit in your program. Save your money for now and await the results of this well-designed NIH trial. References: Ernst E. Chelation therapy for coronary heart disease: An overview of all clinical investigations. Am Heart J 2000 Jul;140(1):139-41. Knudtson ML, Wyse DG, Galbraith PD et al. Chelation therapy for ischemic heart disease: a randomized controlled trial. JAMA 2002 Jan 23-30;287(4):481-6.>